The US government recently entered a $456 million contract with Johnson & Johnson to manufacture coronavirus vaccine.
And, according to Forbes, it is the largest vaccine contract in the history. The company is also being paid to work on new antiviral in order to treat the novel infection.
Contrary to other pharmaceutical companies, J&J has not even begun clinical trials for either antiviral or vaccine; however, it claims that the human trials will start by September, with Trump administration backing the whole process.
However, even Johnson & Johnson is highly unlikely to introduce the vaccine by early 2021; contrary to what the company claims. The company has collaborated with Biomedical and Advanced Research and Development Authority (BARDA) in order to make the drug.
BARDA is a part of the US HHS’ office of ASPR (Assistant Secretary for Preparedness and Response), which is leading the efforts to make vaccines and drugs for coronavirus, which was affected over 140,000 people alone in America.
The company is aligning with the investment of the government with its research and development efforts, totalling the overall budget for project to over $ 1 billion.
The company is all geared up to ramp the production across its 125 facilities across the nations with the objective of making one billion doses of coronavirus vaccine. While the testing is yet to start, the company had begun researching about the vaccine from early January itself.
Johnson & Johnson on Monday announced that one of the vaccine candidates had proven to be quite promising and it would be going ahead with further students.
However, it is still going to be a long time before the vaccine is tested on a person. The pharmaceutical giant has worked to manufacture a vaccine for HIV, ZIKA, and Ebola.
Share this post with your friends and family :)
Recommended Video:
“Controversial ‘Cult’ Leader Claims He Can Change The Weather I TRULY”
[rumble video_id=v3rs7v domain_id=u7nb2]